Blood News and Research

RSS

Simple blood test may identify patients at high risk of neurotoxic complications after CAR-T cell therapy

Cell-based immunotherapy called CAR-T cell therapy has revolutionized the treatment of several cancers.

1 Sep 2022

Study shows encouraging therapeutic options for patients with relapsed multiple myeloma

Mount Sinai researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line treatment with bispecific antibodies fails.

1 Sep 2022

People of African-Caribbean heritage living with diabetes have greater kidney disease risk

New research confirms for the first time that ethnicity is a risk factor for developing kidney disease in people with Type 1 diabetes.

1 Sep 2022

Less is more: early short-course rapamycin effective in sustained anti-aging effects

A new study shows that a brief treatment period could have the same anti-aging efficacy and duration of effect but without the potentially serious adverse effects of chronic administration.

1 Sep 2022

How does origin impact antiviral immune response?

A new study observed differential antiviral responses in Indian and European individuals.

1 Sep 2022

Can SARS-CoV-2 transmission occur from an infected dead body?

In new research, researchers determined whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be transmitted from a dead body.

1 Sep 2022

Cell Counting Without Slides to Reduce Waste and Cost

Until recently, cells were typically counted on a reusable quartz hemocytometer.

From DeNovix Inc. 1 Sep 2022

New case study provides comprehensive characterization and follow-up of monkeypox infection

In a recent monkeypox case in Sweden, scientists focused on clinical symptoms, viral kinetics, and microbial diagnostics.

31 Aug 2022

The currently available evidence on viral-induced parkinsonism

A new review attempts to summarize all known about the relationship between viral illness and parkinsonian disorders to facilitate further research.

31 Aug 2022

Immunosuppressive therapies for COVID-19 treatment

In a new study, researchers assessed the impact of baricitinib, netakimab, and tocilizumab against coronavirus disease 2019 (COVID-19).

31 Aug 2022

The most recent evidence about phylogenesis, pathogenesis, prevention, and treatment for monkeypox

A new review sheds light on the origins of this virus and recently acquired knowledge about its disease mechanism and the preventive and therapeutic measures appropriate in this situation.

31 Aug 2022

Research provides a major step forward to growing human kidney in a dish

Kidney disease affects one in nine adults globally and the incidence of kidney failure is steadily rising around the world.

30 Aug 2022

Leukemia drug successfully disrupts HER2-positive brain metastasis in animal studies

In animal studies led by researchers at Duke Cancer Institute, a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.

30 Aug 2022

Study uncovers molecular changes in the brain’s blood vessels caused by Alzheimer’s susceptibility gene

Recent breakthroughs have revealed a great deal about Alzheimer's disease, but researchers have yet to paint a complete picture of how genetic risk for the illness causes the brain damage that ultimately leads to memory loss and cognitive decline.

30 Aug 2022

Italian study finds SARS-CoV-2 in clinical samples collected before December 2019

Researchers discuss the association of SARS-CoV-2 with morbilliform skin rash and confirms viral circulation in September 2019.

30 Aug 2022

Immune cells beyond CAR-T cells affect the durability of response to BCMA CAR T therapy in myeloma

Patients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer markers of immune cell exhaustion, and distinct changes to immune cell populations were more likely to have longer progression-free survival (PFS) after treatment with BCMA-targeted T-cell therapy.

30 Aug 2022

Blood News and Research

Simple blood test may identify patients at high risk of neurotoxic complications after CAR-T cell therapy

Study shows encouraging therapeutic options for patients with relapsed multiple myeloma

People of African-Caribbean heritage living with diabetes have greater kidney disease risk

Less is more: early short-course rapamycin effective in sustained anti-aging effects

How does origin impact antiviral immune response?

Can SARS-CoV-2 transmission occur from an infected dead body?

Cell Counting Without Slides to Reduce Waste and Cost

New case study provides comprehensive characterization and follow-up of monkeypox infection

The currently available evidence on viral-induced parkinsonism

Immunosuppressive therapies for COVID-19 treatment

The most recent evidence about phylogenesis, pathogenesis, prevention, and treatment for monkeypox

Research provides a major step forward to growing human kidney in a dish

Leukemia drug successfully disrupts HER2-positive brain metastasis in animal studies

Study uncovers molecular changes in the brain’s blood vessels caused by Alzheimer’s susceptibility gene

Italian study finds SARS-CoV-2 in clinical samples collected before December 2019

Immune cells beyond CAR-T cells affect the durability of response to BCMA CAR T therapy in myeloma

Does Langya virus pose a spillover threat?

New treatment may be effective in addressing the long-term effects of preeclampsia

Using human tissue models to improve treatment and diagnosis of heart attacks

A simple and low-cost method to identify valve dysfunction

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News